DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Pro B, Advani R, Brice P et al.
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
J Clin Oncol 2012;
30: 2190-2196
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.